TAKE MY BREATH AWAY - PowerPoint PPT Presentation

1 / 39
About This Presentation
Title:

TAKE MY BREATH AWAY

Description:

TAKE MY BREATH AWAY ... Ali Hasan May Harker Anna Harrison-Murray Amer Ullah MB VITAL SIGNS INVESTIGATIONS ECG Blood Analysis Chest Radiography CT Scan ... – PowerPoint PPT presentation

Number of Views:93
Avg rating:3.0/5.0
Slides: 40
Provided by: Compute266
Category:

less

Transcript and Presenter's Notes

Title: TAKE MY BREATH AWAY


1
TAKE MY BREATH AWAY...
  • Ali Hasan
  • May Harker
  • Anna Harrison-Murray
  • Amer Ullah

2
MB
  • A 62 year old Caucasian woman breathing quickly,
    who arrived in England from Australia three weeks
    ago
  • Complained of feeling lousy

3
SYMPTOMS
  • One episode of haemoptysis
  • A tight chest affecting breathing - RR 20 on
    admission
  • 3/7 before attending AE first presentation
    of illness was aching knee and ankle joints.
  • Left shoulder pain later emerged

4
ALSO
  • Anorexia, nausea, and vomiting
  • Dizziness, with one marked episode of confusion
    and loss of balance
  • Hot and cold flushes
  • Feeling very tired
  • Hot and cold flushes
  • Profound lethargy
  • Nausea and vomiting

5
PAST MEDICAL HISTORY
  • Previous episode of pneumonia, age 31.
  • Hot and cold flushes previously well
  • controlled by HRT.
  • Hallux rigidus
  • High cholesterol 7.5 (normal
    4 - lt6).

6
AND
  • Occasional headaches when overworked.
  • Neurodermatitis which has not recurred for
    years.

7
  • SURGICAL HISTORY
  • Removal of fibroadenoma in the right breast
  • Tubal ligation

8
  • CURRENT MEDICATION
  • Remifem, an OTC HRT replacement
  • ALLERGIES
  • An adverse reaction to voltarol which caused
    paraesthesia in her foot.

9
  • FAMILY HISTORY
  • No illnesses mentioned in daughters
  • Mother had a cholesterol problem, for which she
    had an endarterectomy and subsequently suffered
    a stroke which left her senile.
  • Maternal grandmother died of rheumatic heart
    disease.

10
  • SOCIAL HISTORY
  • An English woman who lives in Australia
  • Migrated to Australia, age 17
  • Lives with her husband, a cattle farmer, two
    daughters
  • Smoked for 12 pack years, age 18-35

11
  • SYSTEMS REVIEW
  • CVS
  • No palpitations, swelling, or previous history
    of SOB

12
SYSTEMS REVIEW CONT.
  • Respiratory system
  • No cough
  • No wheezing
  • Occasional nasal drip

13
SYSTEMS REVIEW CONT
  • GU System
  • Increased thirst
  • Went to the toilet 5x/24h
  • No urinary urgency, and usually one episode of
    nocturia per night
  • Two past urinary infections

14
SYSTEMS REVIEW CONT
  • GI System
  • Patient has not eaten, and there were no bowel
    motions since presentation 3/7 ago.
  • Patient suffered from plenty of wind.
  • No tenderness or pain.

15
VITAL SIGNS
BP 135/69 Temp. 38.6 Pulse 100 reg
RR 20 O2 Sat 91 (air) GCS 15
CLINICAL EXAMINATION
CVS abnormalities detected Resp
GI abnormalities detected
XX XX
16
INVESTIGATIONS
  • ECG
  • Blood Analysis
  • Chest Radiography
  • CT Scan
  • Microbiology

17
BLOOD ANALYSIS
18
  • ECG
  • Tachycardic sinus rhythm
  • CHEST RADIOGRAPHY
  • Patchy consolidation left lung
  • Slight left pleural effusion
  • CT SCAN

19
(No Transcript)
20
(No Transcript)
21
MICROBIOLOGY
  • Blood Cultures
  • Blood and Sputum Gram Stains
  • Antibiotic Sensitivity Tests
  • Legionella Titre

22
  • FOLLOW UP
  • 3/7 later
  • Patient appeared visibly better
  • IV antibiotics and fluid had been stopped
    antibiotics were now oral
  • Nausea stopped 2/7 after admission

23
FOLLOW UP CONT
  • Chest no longer tight. Breaths deeper but
    still some pain on left side when taking very
    deep breaths
  • An intermittent dry unproductive cough appeared
    2/7 after admission. No further sputum production
    or haemoptysis - referred to physio

24
  • MORE FOLLOW UP
  • Patient now eating small meals and resumed bowel
    movements
  • No further dizziness, but still the occasional
    flush

25
  • AND FINALLY
  • Some lethargy.
  • Vital signs good. Pulse around 76, temp 36.6,
    resp rate around 15.
  • Discharge planned 3/7 after.

26
PATHOLOGY
  • DEFINITION
  • Inflammation of the lung parenchyma -
    exudative solidification (consolidation)
  • CAUSES
  • Bacterial (most common)
    Other

27
EPIDEMIOLOGY
  • Incidence of CAP - 12 per 1000 adults
  • CAP accounts for 5-12 of all LRTIs
  • Approximately 10 require hospitalisation

28
EPIDEMIOLOGY CONT
  • Mortality reduced by effective use of
    antibiotics but remains dangerous condition and a
    major cause of death in over 70s
  • - Mx community lt 1 - Mx in hospital
    Approximately 10

29
CLASSIFICATION (1)
  • COMMUNITY AQCUIRED (CAP)
  • - Primary or secondary
  • - Mainly Gram ve bacteria
  • HOSPITAL ACQUIRED
  • - Acquired gt 48hrs after admission
  • - Mostly caused by Gram -ve bacteria
  • - Problem with antibiotic resistance

30
CLASSIFICATION (2)
BY SITE
  • DIFFUSE (LOBULAR)
  • - patchy consolidation
  • - extension of pre-existing disease
  • - extremely common esp. infancy and old age
  • LOCALISED (LOBAR)
  • - involvement of large portion / entire lobe
  • - infrequent due to antibiotic effectiveness

31
CLASSIFICATION (3)
  • BY AETIOLOGY
  • COMMON ORGANISMS
  • - Streptococcus Pneumoniae (60-75)
  • - Mycoplasma Pneumoniae (5-18)
  • - Influenza A (usually with bacterial)
  • - Haemophilus influenzae
  • - Staphylococcus aureus
  • - Legionella species
  • - Chlamydia psittaci

32
CLINICAL FEATURES
  • Vary according to immune system and infecting
    agent
  • Symptoms
  • - Malaise
  • - high temp (up to 39.5)
  • - pleuritic pain
  • - dyspnoea
  • - cough
  • - purulent / rusty sputum
  • Signs
  • - fever
  • - cyanosis
  • - confusion
  • - tachypnoea
  • - tachycardia
  • - consolidation signs
  • - pleural rub

33
COMPLICATIONS
  • Respiratory failure
  • Hypotension
  • Atrial fibrilation
  • Pleural effusion
  • Empyema
  • Lung abscess
  • Organisation of exudate
  • Bacteremic dissemintion

34
  • MANAGEMENT 1



Mild community acquired
Nonsmoking adults lt 60 yrs
Smoking adults gt 60 yrs
Erythromycin 500 mg X 3 or Clarithromycin 250 mg
x 2
Cefaclor 500 mg x3
35
MANAGEMENT 2
  • Patients with severe pneumonia best managed on an
    intensive care unit

Severe community acquired
i.v. 6 h Cefuroxime 1.5 g Clarithromycin 500 mg
12 h
36
MANAGEMENT OF MB
  • Severe community acquired pneumonia
  • No causative organism identified but L.
    pneumophilia Ag test (urine) negative

37
DRUGS 1
  • Regular
  • CEFOTAXIME (broad spectrum antibiotic) 1g i.v.
    tds
  • ERYTHROMYCIN 500 mg oral qds
  • PARACETAMOL 1g oral qds
  • METOCLOPRAMIDE 10mg i.v. tds (for nausea -
    side-effect of antibiotics)

38
DRUGS 2
  • As Required
  • DIHYDROCODEINE 30 mg oral (for pleuritic chest
    pain)
  • CYCLIZINE (for nausea/vomiting) 50 mg oral
  • Saline

39
OTHER
  • O2 therapy for hypoxaemia
  • Fluids encouraged to avoid dehydration
  • Seen by chest physiotherapist due to inability to
    expectorate
  • Antibiotics shifted to oral route after 3 days of
    i.v.
Write a Comment
User Comments (0)
About PowerShow.com